| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-10 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |